567 related articles for article (PubMed ID: 26350728)
21. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.
Cammarata-Scalisi F; Callea M; Martinelli D; Willoughby CE; Tadich AC; Araya Castillo M; Lacruz-Rengel MA; Medina M; Grimaldi P; Bertini E; Nevado J
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328058
[TBL] [Abstract][Full Text] [Related]
22. Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.
Levy T; Gluckman J; Siper PM; Halpern D; Zweifach J; Filip-Dhima R; Holder JL; Trelles MP; Johnson K; Bernstein JA; Berry-Kravis E; Powell CM; Soorya LV; Thurm A; Buxbaum JD; Sahin M; Kolevzon A; Srivastava S;
J Neurodev Disord; 2024 May; 16(1):25. PubMed ID: 38730350
[TBL] [Abstract][Full Text] [Related]
23. Neurocognitive follow-up in adult siblings with Phelan-McDermid syndrome due to a novel SHANK3 splicing site mutation.
Kankuri-Tammilehto M; Sauna-Aho O; Arvio M
Mol Genet Genomic Med; 2021 Dec; 9(12):e1780. PubMed ID: 34369668
[TBL] [Abstract][Full Text] [Related]
24. Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome.
Mitz AR; Philyaw TJ; Boccuto L; Shcheglovitov A; Sarasua SM; Kaufmann WE; Thurm A
Eur J Hum Genet; 2018 Mar; 26(3):293-302. PubMed ID: 29358616
[TBL] [Abstract][Full Text] [Related]
25. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.
Schön M; Lapunzina P; Nevado J; Mattina T; Gunnarsson C; Hadzsiev K; Verpelli C; Bourgeron T; Jesse S; van Ravenswaaij-Arts CMA; ; Hennekam RC
Eur J Med Genet; 2023 Jul; 66(7):104754. PubMed ID: 37003575
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic Variability in Phelan-McDermid Syndrome and Its Putative Link to Environmental Factors.
Boccuto L; Mitz A; Abenavoli L; Sarasua SM; Bennett W; Rogers C; DuPont B; Phelan K
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328081
[TBL] [Abstract][Full Text] [Related]
27. Deletion syndrome 22q13: what the dentist should know to manage children with Phelan-McDermid syndrome effectively.
Ivanoff C; Ivanoff AE
J Tenn Dent Assoc; 2014; 94(1):15-8; quiz 19-20. PubMed ID: 25241497
[TBL] [Abstract][Full Text] [Related]
28. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
[TBL] [Abstract][Full Text] [Related]
29. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
Oberman LM; Boccuto L; Cascio L; Sarasua S; Kaufmann WE
Orphanet J Rare Dis; 2015 Aug; 10():105. PubMed ID: 26306707
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome.
Schenkel LC; Aref-Eshghi E; Rooney K; Kerkhof J; Levy MA; McConkey H; Rogers RC; Phelan K; Sarasua SM; Jain L; Pauly R; Boccuto L; DuPont B; Cappuccio G; Brunetti-Pierri N; Schwartz CE; Sadikovic B
Clin Epigenetics; 2021 Jan; 13(1):2. PubMed ID: 33407854
[TBL] [Abstract][Full Text] [Related]
31. Touchscreen learning deficits and normal social approach behavior in the Shank3B model of Phelan-McDermid Syndrome and autism.
Copping NA; Berg EL; Foley GM; Schaffler MD; Onaga BL; Buscher N; Silverman JL; Yang M
Neuroscience; 2017 Mar; 345():155-165. PubMed ID: 27189882
[TBL] [Abstract][Full Text] [Related]
32. A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.
Upadia J; Gonzales PR; Atkinson TP; Schroeder HW; Robin NH; Rudy NL; Mikhail FM
Am J Med Genet A; 2018 Dec; 176(12):2791-2797. PubMed ID: 30216695
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder.
Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL
Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255
[TBL] [Abstract][Full Text] [Related]
34. Dissecting the 22q13 region to explore the genetic and phenotypic diversity of patients with Phelan-McDermid syndrome.
Vitrac A; Leblond CS; Rolland T; Cliquet F; Mathieu A; Maruani A; Delorme R; Schön M; Grabrucker AM; van Ravenswaaij-Arts C; Phelan K; Tabet AC; Bourgeron T
Eur J Med Genet; 2023 May; 66(5):104732. PubMed ID: 36822569
[TBL] [Abstract][Full Text] [Related]
35. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
Slezak R; Laczmańska I
Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
[TBL] [Abstract][Full Text] [Related]
36. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).
Phelan K; McDermid HE
Mol Syndromol; 2012 Apr; 2(3-5):186-201. PubMed ID: 22670140
[TBL] [Abstract][Full Text] [Related]
37. The deletion 22q13 syndrome: a new case.
Karaman A; Aydin H; Geçkinli B; Göksu K
Genet Couns; 2015; 26(1):53-60. PubMed ID: 26043508
[TBL] [Abstract][Full Text] [Related]
38. Phelan-McDermid syndrome due to
Egger JIM; Verhoeven WMA; Groenendijk-Reijenga R; Kant SG
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28963116
[TBL] [Abstract][Full Text] [Related]
39. Co-occurrence of Metachromatic Leukodystrophy in Phelan-McDermid Syndrome.
Mingbunjerdsuk D; Wong M; Bozarth X; Sun A
J Child Neurol; 2021 Feb; 36(2):148-151. PubMed ID: 32991243
[TBL] [Abstract][Full Text] [Related]
40. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome).
Kurtas N; Arrigoni F; Errichiello E; Zucca C; Maghini C; D'Angelo MG; Beri S; Giorda R; Bertuzzo S; Delledonne M; Xumerle L; Rossato M; Zuffardi O; Bonaglia MC
J Med Genet; 2018 Apr; 55(4):269-277. PubMed ID: 29378768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
